Phase 1 Four-Arm Parallel Group, Placebo-Controlled Study To Evaluate The Effects Of Single Doses Of PF- 05175157 At Three Dose Levels On Pharmacodynamic And Metabolic Parameters In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 09 Jul 2012
At a glance
- Drugs PF 5175157 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 09 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 May 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.